Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00538395

Enrollment

100

Registered

2007-10-02

Start date

2007-09-30

Completion date

2013-09-30

Last updated

2011-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Intensive sequential chemotherapy with Adriamycin Taxol and Cytoxan in the treatment of locally advanced breast cancer

Interventions

DRUGAdriamycin, Taxol and Cytoxan

Chemotherapy

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with locally advanced breast cancer

Design outcomes

Primary

Measure	Time frame
Effectiveness	overall

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026